肠易激综合征的中医诊疗现状、策略与展望OA

Irritable bowel syndrome(IBS)is a functional bowel disorder characterized primarily by abdominal pain and altered defecation habits.In recent years,traditional Chinese medicine(TCM)has made progress in multi-ple aspects of IBS research and treatment,including syndrome distribution,development of TCM formulas,clinical efficacy evaluation,external therapies,and psychosocial regulation.However,it still faces challenges such as over-reliance on symptomatic manifestations rather than biomarkers for diagnostic criteria,and the lack of high-quality evi-dence-based data supporting the efficacy of TCM formulas in treating IBS.This paper proposed that TCM diagnosis and treatment of IBS should adhere to the strategy of integrating the holistic concept with syndrome differentiation and treatment,combining TCM external therapies such as acupuncture,moxibustion and acupoint application),and emphasizing individualized diagnosis and treatment for psychosomatic abnormalities.Future research should integrate multi-omics technologies,artificial intelligence and other methods to deepen the understanding of the pathogenesis of IBS and the mechanisms of TCM formulas,so as to promote the standardization and internationalization of TCM in the diagnosis and treatment of IBS.